Related Experiment Video
Updated: Jun 8, 2026

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
Identification, isolation and characterization of a new degradation product in sultamicillin drug substance
Vundavilli Jagadeesh Kumar1, P Badarinadh Gupta, K S R Pavan Kumar
1Aurobindo Pharma Limited, Research Centre, 313 Bachupally, Qutubullapur Mandal, Hyderabad 500 090, India.
Abstract:
A new degradant of sultamicillin drug substance was found during the gradient reverse phase HPLC analysis of stability storage samples. The level of this degradant impurity was observed up to 1.0%. The impurity (formaldehyde adduct with 5-oxo-4-phenylimidazolidin-1-yl moiety) was identified by LC/MS and was characterized by ((1)H NMR, (13)C NMR, 2D-NMR ((1)H-(1)H COSY, NOESY, HSQC and HMBC), LC/MS/MS, MS/TOF, elemental analysis and IR. This impurity was prepared by isolation and co-injected into HPLC system to confirm the retention time.
